Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin for Stage IB-IVA Cervical Cancer: An International Multicenter Phase 2 Clinical Trial (INTERTECC-2)

被引：1
|
作者：
Singh, Anshul [1 ]
机构：
[1] Kasturba Med Coll & Hosp, Dept Radiotherapy & Oncol, Manipal, Karnataka, India
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 98卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.02.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：482 / 483
页数：3
相关论文
共 40 条
  • [1] Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)
    Mell, Loren K.
    Sirak, Igor
    Wei, Lichun
    Tarnawski, Rafal
    Mahantshetty, Umesh
    Yashar, Catheryn M.
    McHale, Michael T.
    Xu, Ronghui
    Honerkamp-Smith, Gordon
    Carmona, Ruben
    Wright, Mary
    Williamson, Casey W.
    Kasaova, Linda
    Li, Nan
    Kry, Stephen
    Michalski, Jeff
    Bosch, Walter
    Straube, William
    Schwarz, Julie
    Lowenstein, Jessica
    Jiang, Steve B.
    Saenz, Cheryl C.
    Plaxe, Steve
    Einck, John
    Khorprasert, Chonlakiet
    Koonings, Paul
    Harrison, Terry
    Shi, Mei
    Mundt, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (03): : 536 - 545
  • [2] Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin for Stage IB-IVA Cervical Cancer: An International Multicenter Phase 2 Clinical Trial (INTERTECC-2) Reply
    Mell, Loren K.
    Sirak, Igor
    Mahantshetty, Umesh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : 483 - 484
  • [3] Phase 2 Multicenter Clinical Trial of Bone Marrow-Sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin for Stage IB-IVA Cervical Cancer
    Mell, L. K.
    Sirak, I.
    Wei, L.
    Tarnawski, R. R.
    Mahantshetty, U. M.
    Yashar, C. M.
    McHale, M. T.
    Wright, M. E.
    Pritz, J.
    Straube, W.
    Xu, R.
    Kasaova, L.
    Michalski, J. M.
    Bosch, W. R.
    Followill, D. S.
    Schwarz, J. K.
    Honerkamp-Smith, G.
    Leif, J. L.
    Saenz, C. C.
    Einck, J. P.
    Koonings, P. P.
    Harrison, T. A.
    Khorprasert, C.
    Shi, M.
    Plaxe, S. C.
    Mundt, A. J., III
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S13 - S13
  • [4] Phase 1 Trial of Bone Marrow Sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Gemcitabine in Stage IB-IVA Cervical Cancer
    Mell, L. K.
    Saenz, C. C.
    Yashar, C. M.
    McHale, M. T.
    Einck, J. P.
    Wright, M. E.
    Noticewala, S. S.
    Xu, R.
    Plaxe, S. C.
    Mundt, A. J., III
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S14 - S14
  • [5] PRELIMINARY QUALITY OF LIFE ANALYSIS FOR THE INTERTECC PHASE II TRIAL OF INTENSITY MODULATED RADIATION THERAPY IN STAGE IB-IVA CERVICAL CANCER
    Pritz, J.
    Wells, K.
    Yashar, C.
    Sirak, I.
    Wei, L.
    Tarnawski, R.
    Mahantshetty, U.
    Khorprasert, C.
    Einck, J.
    Wyss, J.
    Wright, M.
    Carmona, R.
    Saenz, C.
    McHale, M.
    Plaxe, S.
    Followill, D.
    Michalski, J.
    Mundt, A.
    Mell, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 611 - 612
  • [6] Bone marrow-sparing intensity modulated radiation therapy versus conventional techniques in cervical cancer patients
    Aydogan, B.
    Ahn, K.
    Tiryaki, H.
    Kochanski, J.
    Mundt, A. J.
    Roeske, J. C.
    Mell, L. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S401 - S401
  • [7] ATLAS-Based Active Bone Marrow-Sparing Intensity Modulated Radiation Therapy for Cervical Cancer
    Li, N.
    Noticewala, S. S.
    Williamson, C. W.
    Shen, H.
    Sirak, I.
    Tarnawski, R. R.
    Mahantshetty, U. M.
    Moore, K. L.
    Mell, L. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S98 - S99
  • [8] Phase III randomized trial of image-guided bone marrow-sparing intensity modulated radiation therapy (IG-BMS-IMRT) for locoregionally advanced cervical cancer: The INTERTECC-3 trial.
    Mell, Loren K.
    Sirak, Igor
    Portelance, Lorraine
    Wolfson, Aaron Howard
    Stewart, Alexandra J.
    Sharma, Dayanand
    Princ, Denis
    Mahantshetty, Umesh
    Nakamura, Mitsuhiro
    Hirata, Kimiko
    Kry, Stephen F.
    Wei, Lichun
    Xu, Ronghui
    Zakeri, Kaveh
    Sojourner, Elena
    Moore, Kevin
    McHale, Michael T.
    Saenz, Cheryl C.
    Yashar, Catheryn M.
    Mundt, Arno James
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Which Bone Marrow Sparing Strategy and Radiotherapy Technology Is Most Beneficial in Bone Marrow-Sparing Intensity Modulated Radiation Therapy for Patients With Cervical Cancer?
    Yu, De-Yang
    Bai, Yan-Ling
    Feng, Yue
    Wang, Le
    Yun, Wei-Kang
    Li, Xin
    Song, Jia-Yu
    Yang, Shan-Shan
    Zhang, Yun-Yan
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [10] Comparison of 2 Contouring Methods of Bone Marrow on CT and Correlation With Hematological Toxicities in Non-Bone Marrow-Sparing Pelvic Intensity-Modulated Radiotherapy With Concurrent Cisplatin for Cervical Cancer
    Mahantshetty, Umesh
    Krishnatry, Rahul
    Chaudhari, Suresh
    Kanaujia, Aarti
    Engineer, Reena
    Chopra, Supriya
    Shrivastava, Shyamkishore
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (08) : 1427 - 1434
1234